Methylphenidate Hydrochloride
Product Images NDC 43598-441

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 43598-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

This appears to be a label of medication called "Methylphenidate Hydrochloride Extended-Release Tablets" with information including the quantity of 100 tablets and dosage of 18mg. The label also includes a reference to "Dr. Roddys" and two sets of alphanumeric code (one possibly a location) "NG 45595 43801" and "ShpuaioiouB 3 36105 B o". Without further context, the purpose or efficacy of this medication or the significance of the codes cannot be determined.*

FDA Label Image

Container2 (Container2)

This text is a label of a medicine bottle. The medicine is Methylphenidate Hydrochloride Extended-Release Tablets, with a strength of 27 mg. The bottle contains 100 tablets and was likely filled by a pharmacy called Dr. Roddys.*

FDA Label Image

Container3 (Container3)

This is a medication label for Methylphenidate Hydrochloride Extended-Release Tablets at a strength of 36 mg.*

FDA Label Image

Container4 (Container4)

The text indicates the details of a medication called Methylphenidate Hydrochloride Extended-Release Tablets, which come in a 54 mg dosage. The manufacturer of the tablets is mentioned as "DrRoddys", but no further information is provided.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

The text describes a study using extended-release tablets of Methylphenidate Hydrochloride to treat symptoms of inattention and overactivity in individuals. The dosage was a maximum of 15 7| BN tablets once daily, compared to a placebo. The study included three weeks, and the efficacy was measured using the Inattention/Overactivity Scale. The results showed a significant reduction in symptoms in the Methylphenidate Hydrochloride group compared to the placebo group in all three weeks of the study.*

FDA Label Image

Figure3 (Figure3)

This appears to be a table or chart showing the results of a study involving a drug called Attentive 2.0, specifically comparing the effects of the drug to a placebo. The drug in question is Methylphenidate Hydrochloride Extended-Release Tablets, which is taken once a day. The chart appears to show the results of testing the drug and the placebo over a period of time after the initial dose. However, there is not enough information to fully understand the study or draw any conclusions from it.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.